This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Eli Lilly & Company
Drug Names(s): atomoxetine hydrochloride, Strattera (0.4% oral solution)
Description: Strattera (Atomoxetine HCl) is a selective norepinephine reuptake inhibitor. It belongs to a new class of treatment that works differently from the other attention-deficit/hyperactivity disorder medications available.
Pink Sheet Strattera FDA Reviewers
Pink Sheet Strattera Clinical Development
Pink Sheet Strattera Clinical Protocols
Additional information available to subscribers only: